Business Wire

CA-VELODYNE-LIDAR

11.1.2021 13:02:33 CET | Business Wire | Press release

Share
Velodyne Lidar Powers Intelligent Traffic Management

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) and University of Nevada, Reno’s Nevada Center for Applied Research today published a white paper that demonstrates lidar sensors’ ability to make transportation infrastructure more efficient, sustainable and safe. The white paper reports results of research using Velodyne’s lidar sensors to improve traffic analytics, increase pedestrian safety, reduce accidents and work toward facilitated use of autonomous vehicles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005118/en/

“Velodyne is excited to provide lidar technology for systems that protect pedestrians at city intersections and reduce traffic accidents. We have a synergistic relationship with the University of Nevada, Reno, which is conducting cooperative research to further the development of safety solutions at the infrastructure level using smart technology. This white paper is important to describe our collaborative work for the safety and well-being of urban communities,” stated Marta Hall, Chief Marketing Officer at Velodyne.

The white paper, called “Roadside Lidar Helping to Build Smart and Safe Transportation Infrastructure,” can be downloaded here . Also available is a video called “Smart Cities: Improving Mobility, Access and Safety with Sensor Technology,” which can be viewed here . The video looks at how lidar can be a catalyst for smart city applications that improve public services and enhance safety and quality of life.

According to the research firm Markets and Markets , the Intelligent Transportation System (ITS) market for roadways is expected to grow from USD 17.9 billion in 2020 to USD 36.5 billion by 2025, at a CAGR of 15.3 percent. This growth can be attributed to increased pedestrian safety concerns, growing traffic congestion problems and smart city developments around the world.

The paper showcases research conducted by the University of Nevada, Reno’s Nevada Center for Applied Research, in conjunction with the Regional Transportation Commission of Washoe County, Regional Transportation Commission of Southern Nevada and the Nevada Department of Transportation. The project has deployed Velodyne’s Ultra Puck lidar sensors with traffic signals in real-world test environments, known as Living Laboratories, in Reno and Henderson, and sponsored by the Nevada Governor’s Office of Economic Development. It leveraged the data captured with Velodyne’s sensors to help improve traffic analytics, congestion management and pedestrian safety.

The project validated the feasibility of using roadside lidar sensors to provide high-accuracy, multimodal traffic trajectories by testing with different sensors, deployment methods and traffic scenarios. It demonstrated that roadside lidar data can support connected-and-autonomous vehicles (CAV), enhance traffic mobility and safety analysis and integrate with existing traffic infrastructure for automatic pedestrian/wildlife warning.

The project also achieved successful implementation of lidar-based automatic rectangular rapid flash beacons (RRFB), which unlike conventional RRFB, not only serve the crosswalk area but provide many additional functions. These include traffic performance data collection, jaywalk event recording and supporting infrastructure to serve CAVs and connected non-motorist roadway users.

Until recently, existing camera-based ITS traffic monitoring technologies have been widely used to study traffic flow rates, occupancy, average speed and spot speed. However, as alternative sensors come onto the market, the weaknesses of camera-based approaches become more apparent. For example, cameras have been shown to suffer in low-light conditions, are prone to optical illusions and do not allow for people’s privacy. It is anticipated that lidar will play a pivotal role in the growth of the ITS market because lidar sensors provide robust 3D data that allows for superior object detection and tracking in a wide variety of lighting and weather conditions while preserving anonymity and trust among the public.

“The white paper captures how lidar technology can be the catalyst for a revolutionary data change that will impact transportation planning and systems, and prepare our roadways for the future,” said Carlos Cardillo, Director, Nevada Center for Applied Research. “Velodyne sensors are powering ‘lidar-enhanced’ roads that address roadway congestion monitoring and near-crash analysis. They are also enabling data communications with connected vehicles to support eco-drive and collision avoidance applications.”

“The Nevada Center for Applied Research is conducting visionary smart cities research that can help significantly improve traffic safety and mitigate roadway dangers,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Their work clearly demonstrates Velodyne’s lidar sensors are ready today to help build smarter, safer transportation infrastructure.”

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne is the first public pure-play lidar company and is known worldwide for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com .

Forward Looking Statements

This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; uncertainties related to Velodyne's estimates of the size of the markets for its products; uncertainties regarding government regulation and adoption of lidar for pedestrian safety, traffic congestion and smart city applications; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; Velodyne's ability to identify and integrate acquisitions; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Link:

ClickThru

Social Media:

https://www.facebook.com/VelodyneLidar/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release

Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release

First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye